Wu, K.-Y.; Crucho, A.; Su, M.; Chen, S.-T.; Hung, C.-H.; Kou, Y.-L.; Liu, Y.-J.; Hsu, T.-C.; Yeh, F.-Y.; Lien, C.-F.;
et al. Synergistic Anticancer Activity of HSP70 Inhibitor and Doxorubicin in Gain-of-Function Mutated p53 Breast Cancer Cells. Biomedicines 2025, 13, 1034.
https://doi.org/10.3390/biomedicines13051034
AMA Style
Wu K-Y, Crucho A, Su M, Chen S-T, Hung C-H, Kou Y-L, Liu Y-J, Hsu T-C, Yeh F-Y, Lien C-F,
et al. Synergistic Anticancer Activity of HSP70 Inhibitor and Doxorubicin in Gain-of-Function Mutated p53 Breast Cancer Cells. Biomedicines. 2025; 13(5):1034.
https://doi.org/10.3390/biomedicines13051034
Chicago/Turabian Style
Wu, Kuan-Yo, Ana Crucho, Mia Su, Sih-Tong Chen, Chen-Hsiu Hung, Yu-Ling Kou, Yu-Jie Liu, Tzu-Chi Hsu, Fang-Yu Yeh, Ching-Feng Lien,
and et al. 2025. "Synergistic Anticancer Activity of HSP70 Inhibitor and Doxorubicin in Gain-of-Function Mutated p53 Breast Cancer Cells" Biomedicines 13, no. 5: 1034.
https://doi.org/10.3390/biomedicines13051034
APA Style
Wu, K.-Y., Crucho, A., Su, M., Chen, S.-T., Hung, C.-H., Kou, Y.-L., Liu, Y.-J., Hsu, T.-C., Yeh, F.-Y., Lien, C.-F., Chen, C.-C., & Cai, B.-H.
(2025). Synergistic Anticancer Activity of HSP70 Inhibitor and Doxorubicin in Gain-of-Function Mutated p53 Breast Cancer Cells. Biomedicines, 13(5), 1034.
https://doi.org/10.3390/biomedicines13051034
